Carticept Medical has received the US Food and Drug Administration (FDA) 510(k) approval for its computer-controlled navigator delivery system (Navigator DS) to automate preparation and delivery of pain relieving medications for joint pain.
Navigator DS prepares physician-prescribed injections from standard multi-dose anesthetic and steroid drug vials.
The system automates accurate medical record keeping by recording the treatment data for transfer to an electronic record management system or direct print-out.
Carticept president and CEO Timothy Patrick said receiving FDA clearance is an important milestone which allows them to launch this proprietary technology to the US orthopedic and sports medicine market.